GSK plc Reports Share Transactions
Ticker: GLAXF · Form: 6-K · Filed: Jul 22, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Jul 22, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-transactions, disclosure, foreign-issuer
TL;DR
GSK bought/sold its own shares in July 2025, check the filing for details.
AI Summary
GSK plc announced on July 22, 2025, that it has conducted transactions involving its own shares. The filing, a Form 6-K, details these share transactions for the month of July 2025. GSK plc is a pharmaceutical preparations company based in London, UK.
Why It Matters
This filing provides transparency on GSK's activities in managing its own share capital, which can impact share price and investor perception.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of share transactions and does not indicate any immediate financial distress or significant operational changes.
Key Players & Entities
- GSK plc (company) — Registrant
- July 2025 (date) — Reporting period for share transactions
- 79 New Oxford Street, London, WC1A 1DG (address) — Principal executive office
- 001-15170 (other) — Commission File Number
FAQ
What type of transactions did GSK plc conduct in its own shares during July 2025?
The filing indicates that GSK plc conducted 'Transaction in own shares' during the month of July 2025.
What is the primary business of GSK plc?
GSK plc is classified under the Standard Industrial Classification code 2834, which corresponds to 'PHARMACEUTICAL PREPARATIONS'.
Where is GSK plc's principal executive office located?
GSK plc's principal executive office is located at 79 New Oxford Street, London, WC1A 1DG.
What form is this SEC filing?
This SEC filing is a Form 6-K, which is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
What is the Commission File Number for GSK plc?
The Commission File Number for GSK plc is 001-15170.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 22, 2025 regarding GSK plc (GLAXF).